🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multi-center, open-label, phase II randomized controlled trial is to e...
Status
Suspended
Location
Sun Yat-sen Memorial Hospital
Start Date
2016-09
Trial ID
NCT02897050
This is a Phase III, randomized, multicenter, international, 2-arm, open-la...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00829166
Treatments Being Tested
Researchers are looking for new ways to treat types of breast cancer that a...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0066)
Start Date
2025-06-30
Trial ID
NCT06966700
Dose escalation of oxaliplatin, gemcitabine and capecitabine in the treatme...
Status
Completed
Location
Washington University School of Medicine
Start Date
2005-03
Trial ID
NCT00660426
Treatments Being Tested
This is a Phase III, randomized, open-label, 3-arm, multicenter, internatio...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-11-28
Trial ID
NCT05629585
Treatments Being Tested
This observational study will evaluate the efficacy and safety of different...
Status
Completed
Location
Szent Margit Hospital
Start Date
2011-07
Trial ID
NCT01696695
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as oxaliplatin and capecitabine...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2006-10
Trial ID
NCT00483405
Treatments Being Tested
This observational study will evaluate the routine clinical use and the saf...
Status
Completed
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01725386
Treatments Being Tested
Diarrhoea is the most commonly reported adverse event (AE) associated with ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-12-17
Trial ID
NCT02294786
Treatments Being Tested
The goal of this study is to evaluate the efficacy and safety of tucatinib ...
Status
Active Not Recruiting
Location
Aichi Cancer Center Hospital ( Site 1013)
Start Date
2021-04-08
Trial ID
NCT04721977
Treatments Being Tested